Project Grant R56DK141683
- Federal Grant Award Summary Boston University Medical Campus received a $817,498 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of February 18, 2026 and completion date of January 31, 2031. The research focuses on understanding and promoting vasculature remodeling and beige adipocyte recruitment in obese adipose tissue as a...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $709,931 Project Grant effective August 15, 2025, through June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research investigating neutrophil regulation of brown adipose tissue (BAT) homeostasis, with the objective of identifying novel therapeutic pathways to treat metabolic diseases...
- Federal Project Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $813,511 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 21, 2025, with a completion date of April 30, 2029. This research project investigates the structural basis of thermogenic mitochondrial respiratory complex assembly in brown and beige adipocytes,...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $840,198 Project Grant award dated July 21, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award extends through April 30, 2029, and supports basic biomedical research aimed at advancing understanding of adipose tissue metabolism and thermogenesis mechanisms relevant to obesity,...
- Federal Project Grant Award Summary Boston University, through its Medical Campus division, received a $168,252 Project Grant award dated September 15, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The five-year award, with completion targeted for July 31, 2030, supports fundamental research investigating the molecular mechanisms of Nuclear Receptor...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $2.64 million to the University of Massachusetts Medical School under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year research project running from September 1, 2025, through August 31, 2029. The research investigates novel mitochondrial mechanisms underlying obesity pathogenesis, with a focus on understanding how...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $803,748 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 5, 2025, through June 30, 2029, supports fundamental research investigating the modulation of insulin signaling in adipocytes (fat cells) and its role in systemic...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $578,846 Project Grant to The Washington University (Office of Sponsored Research Services) effective February 1, 2026, through January 31, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports research investigating brown adipose tissue (BAT)-derived nidogen-2 as a potential diabetes therapeutic. The research...
- Federal Grant Award Summary Rockefeller University received a $773,112 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 5, 2025, through June 30, 2030. This award funds basic biomedical research investigating the transcriptional mechanisms controlling adipocyte (fat cell) formation and function through nuclear receptor...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $672,737 Project Grant to the University of California, Los Angeles (UCLA) effective August 15, 2025, through July 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates the molecular mechanisms underlying dysregulated insulin secretion in obesity, specifically examining the role of...
Tufts University School of Medicine received a $232,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on March 12, 2026, with completion targeted for February 28, 2027. The research focuses on investigating the role of Interferon Regulatory Factor 8 (IRF8), a transcription factor expressed in adipocytes, in regulating brown and white adipose tissue metabolism and its relationship to diet-induced obesity. The study will examine how IRF8 expression changes in response to high-fat diet consumption and its impact on thermogenesis, chronic inflammation, hepatic steatosis, and systemic insulin resistance in mice. The primary deliverables from this project include foundational research findings on IRF8's specific mechanisms in white and brown adipocytes, characterization of gene expression patterns and metabolic pathways altered by IRF8 in response to both low-fat and high-fat diets, and analysis of IRF8's role in obesity-associated metabolic complications. This research will advance scientific understanding of adipocyte dysfunction in diet-induced obesity and may inform future therapeutic strategies for metabolic diseases and insulin resistance.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $232.0k | 3/12/26 |